FindTrial
Sign In

The relationship among temperature, inhaled anesthetic concentration and the depth of anesthesia under cardiopulmonary bypass

Comparison of myocardial protection between sevoflurane and propofol in patients undergoing valve replacement with cardiopulmonary bypass

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-OOC-14005658
Enrollment
Unknown
Registered
2014-12-10
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

valve disorder

Interventions

Control group:Different temperature
Isoflurane group:Different Temperrature
Sevoflurane group:Different temperature

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ASA II-IV; no disorder of consciousness or hearing;needs to valve replacement under cardiopulmonary bypass; adult patients.

Exclusion criteria

Exclusion criteria: patients with infection,active rheumatism or disorder of immune system; Acute Myocardial Infarction in 3 months; severe disfunction of liver or kedney.

Design outcomes

Primary

MeasureTime frame
Auditory evoked potential index;BIS index;Inhaled anesthetic concentration;—

Countries

China

Contacts

Public ContactYang XiaoLin
yang_xl_yang@126.com+86 13990826183

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026